{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:13:49Z","timestamp":1791148429598,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T00:00:00Z","timestamp":1283731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T00:00:00Z","timestamp":1283731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2011,1,13]]},"DOI":"10.1038\/onc.2010.411","type":"journal-article","created":{"date-parts":[[2010,9,6]],"date-time":"2010-09-06T10:23:39Z","timestamp":1283768619000},"page":"190-200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptor"],"prefix":"10.1038","volume":"30","author":[{"given":"J","family":"Dwyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Le Guelte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E M","family":"Galan Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sumbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Carlotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Douguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J S","family":"Gutkind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Grange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Dupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gavard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,6]]},"reference":[{"key":"BFonc2010411_CR1","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1182\/blood.V93.12.4232","volume":"93","author":"G Ascherl","year":"1999","unstructured":"Ascherl G, Hohenadl C, Schatz O, Shumay E, Bogner J, Eckhart L et al (1999). Infection with human immunodeficiency virus-1 increases expression of vascular endothelial cell growth factor in T cells: implications for acquired immunodeficiency syndrome-associated vasculopathy. Blood 93: 4232\u20134241.","journal-title":"Blood"},{"key":"BFonc2010411_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/34193","volume":"391","author":"C Bais","year":"1998","unstructured":"Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS et al. (1998). G-protein-coupled receptor of Kaposi\u2032s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391: 86\u201389.","journal-title":"Nature"},{"key":"BFonc2010411_CR3","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nm1291","volume":"11","author":"DF Barber","year":"2005","unstructured":"Barber DF, Bartolome A, Hernandez C, Flores JM, Redondo C, Fernandez-Arias C et al. (2005). PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat Med 11: 933\u2013935.","journal-title":"Nat Med"},{"key":"BFonc2010411_CR4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/nm1284","volume":"11","author":"M Camps","year":"2005","unstructured":"Camps M, Ruckle T, Ji H, Ardissone V, Rintelen F, Shaw J et al. (2005). Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat Med 11: 936\u2013943.","journal-title":"Nat Med"},{"key":"BFonc2010411_CR5","first-page":"263","volume":"312","author":"E Cesarman","year":"2007","unstructured":"Cesarman E, Mesri EA . (2007). Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. Curr Top Microbiol Immunol 312: 263\u2013287.","journal-title":"Curr Top Microbiol Immunol"},{"key":"BFonc2010411_CR6","doi-asserted-by":"publisher","first-page":"8361","DOI":"10.1158\/0008-5472.CAN-08-0878","volume":"68","author":"R Chaisuparat","year":"2008","unstructured":"Chaisuparat R, Hu J, Jham BC, Knight ZA, Shokat KM, Montaner S . (2008). Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma. Cancer Res 68: 8361\u20138368.","journal-title":"Cancer Res"},{"key":"BFonc2010411_CR7","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM et al. (1994). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865\u20131869.","journal-title":"Science"},{"key":"BFonc2010411_CR8","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1128\/JVI.76.7.3421-3439.2002","volume":"76","author":"CJ Chiou","year":"2002","unstructured":"Chiou CJ, Poole LJ, Kim PS, Ciufo DM, Cannon JS, ap Rhys CM et al. (2002). Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus. J Virol 76: 3421\u20133439.","journal-title":"J Virol"},{"key":"BFonc2010411_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrm1357","volume":"5","author":"E Dejana","year":"2004","unstructured":"Dejana E . (2004). Endothelial cell-cell junctions: happy together. Nat Rev Mol Cell Biol 5: 261\u2013270.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2010411_CR10","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1073\/pnas.96.8.4546","volume":"96","author":"N Dupin","year":"1999","unstructured":"Dupin N, Fisher C, Kellam P, Ariad S, Tulliez M, Franck N et al. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi\u2032s sarcoma, multicentric Castleman\u2032s disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 96: 4546\u20134551.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010411_CR11","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/sj.jid.5700132","volume":"126","author":"N Dupin","year":"2006","unstructured":"Dupin N, Grange PA . (2006). Looking for the target cell of Kaposi's sarcoma-associated herpesvirus. J Invest Dermatol 126: 545\u2013547.","journal-title":"J Invest Dermatol"},{"key":"BFonc2010411_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/ncb1486","volume":"8","author":"J Gavard","year":"2006","unstructured":"Gavard J, Gutkind JS . (2006). VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol 8: 1223\u20131234.","journal-title":"Nat Cell Biol"},{"key":"BFonc2010411_CR13","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1128\/MCB.01304-08","volume":"29","author":"J Gavard","year":"2009","unstructured":"Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, Weigert R et al. (2009). A role for a CXCR2\/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 29: 2469\u20132480.","journal-title":"Mol Cell Biol"},{"key":"BFonc2010411_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1242\/jcs.00857","volume":"117","author":"J Gavard","year":"2004","unstructured":"Gavard J, Lambert M, Grosheva I, Marthiens V, Irinopoulou T, Riou JF et al. (2004). Lamellipodium extension and cadherin adhesion: two cell responses to cadherin activation relying on distinct signalling pathways. J Cell Sci 117: 257\u2013270.","journal-title":"J Cell Sci"},{"key":"BFonc2010411_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.devcel.2007.10.019","volume":"14","author":"J Gavard","year":"2008","unstructured":"Gavard J, Patel V, Gutkind JS . (2008). Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. Dev Cell 14: 25\u201336.","journal-title":"Dev Cell"},{"key":"BFonc2010411_CR16","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1172\/JCI26666","volume":"116","author":"MG Grisotto","year":"2006","unstructured":"Grisotto MG, Garin A, Martin AP, Jensen KK, Chan P, Sealfon SC et al. (2006). The human herpesvirus 8 chemokine receptor vGPCR triggers autonomous proliferation of endothelial cells. J Clin Invest 116: 1264\u20131273.","journal-title":"J Clin Invest"},{"key":"BFonc2010411_CR17","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1172\/JCI200417803","volume":"113","author":"A Grundhoff","year":"2004","unstructured":"Grundhoff A, Ganem D . (2004). Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113: 124\u2013136.","journal-title":"J Clin Invest"},{"key":"BFonc2010411_CR18","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1038\/sj.onc.1210817","volume":"27","author":"D Martin","year":"2008","unstructured":"Martin D, Galisteo R, Ji Y, Montaner S, Gutkind JS . (2008). An NF-kappaB gene expression signature contributes to Kaposi\u2032s sarcoma virus vGPCR-induced direct and paracrine neoplasia. Oncogene 27: 1844\u20131852.","journal-title":"Oncogene"},{"key":"BFonc2010411_CR19","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1056\/NEJMc070508","volume":"357","author":"T Maurer","year":"2007","unstructured":"Maurer T, Ponte M, Leslie K . (2007). HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 357: 1352\u20131353.","journal-title":"N Engl J Med"},{"key":"BFonc2010411_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/00001622-200003000-00013","volume":"12","author":"RT Mitsuyasu","year":"2000","unstructured":"Mitsuyasu RT . (2000). Update on the pathogenesis and treatment of Kaposi sarcoma. Curr Opin Oncol 12: 174\u2013180.","journal-title":"Curr Opin Oncol"},{"key":"BFonc2010411_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1097\/QAD.0b013e3283262a8d","volume":"23","author":"P Monini","year":"2009","unstructured":"Monini P, Sgadari C, Grosso MG, Bellino S, Di Biagio A, Toschi E et al. (2009). Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir. AIDS 23: 534\u2013538.","journal-title":"AIDS"},{"key":"BFonc2010411_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1535-6108(02)00237-4","volume":"3","author":"S Montaner","year":"2003","unstructured":"Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y et al. (2003). Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3: 23\u201336.","journal-title":"Cancer Cell"},{"key":"BFonc2010411_CR23","first-page":"2641","volume":"61","author":"S Montaner","year":"2001","unstructured":"Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS . (2001). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt\/protein kinase B. Cancer Res 61: 2641\u20132648.","journal-title":"Cancer Res"},{"key":"BFonc2010411_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1158\/0008-5472.CAN-05-1026","volume":"66","author":"S Montaner","year":"2006","unstructured":"Montaner S, Sodhi A, Ramsdell AK, Martin D, Hu J, Sawai ET et al. (2006). The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res 66: 168\u2013174.","journal-title":"Cancer Res"},{"key":"BFonc2010411_CR25","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1182\/blood-2003-12-4436","volume":"104","author":"S Montaner","year":"2004","unstructured":"Montaner S, Sodhi A, Servitja JM, Ramsdell AK, Barac A, Sawai ET et al. (2004). The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Blood 104: 2903\u20132911.","journal-title":"Blood"},{"key":"BFonc2010411_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ccr.2007.01.015","volume":"11","author":"AD Mutlu","year":"2007","unstructured":"Mutlu AD, Cavallin LE, Vincent L, Chiozzini C, Eroles P, Duran EM et al. (2007). In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 11: 245\u2013258.","journal-title":"Cancer Cell"},{"key":"BFonc2010411_CR27","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","volume":"99","author":"E Oksenhendler","year":"2002","unstructured":"Oksenhendler E, Boulanger E, Galicier L, Du MQ, Dupin N, Diss TC et al. (2002). High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99: 2331\u20132336.","journal-title":"Blood"},{"key":"BFonc2010411_CR28","doi-asserted-by":"publisher","first-page":"F35","DOI":"10.1097\/00002030-199705000-00001","volume":"11","author":"JM Orenstein","year":"1997","unstructured":"Orenstein JM, Alkan S, Blauvelt A, Jeang KT, Weinstein MD, Ganem D et al. (1997). Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 11: F35\u2013F45.","journal-title":"AIDS"},{"key":"BFonc2010411_CR29","doi-asserted-by":"publisher","first-page":"11902","DOI":"10.1128\/JVI.01042-08","volume":"82","author":"LW Qian","year":"2008","unstructured":"Qian LW, Greene W, Ye F, Gao SJ . (2008). Kaposi's sarcoma-associated herpesvirus disrupts adherens junctions and increases endothelial permeability by inducing degradation of VE-cadherin. J Virol 82: 11902\u201311912.","journal-title":"J Virol"},{"key":"BFonc2010411_CR30","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nm0302-225","volume":"8","author":"C Sgadari","year":"2002","unstructured":"Sgadari C, Barillari G, Toschi E, Carlei D, Bacigalupo I, Baccarini S et al. (2002). HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma. Nat Med 8: 225\u2013232.","journal-title":"Nat Med"},{"key":"BFonc2010411_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","volume":"10","author":"A Sodhi","year":"2006","unstructured":"Sodhi A, Chaisuparat R, Hu J, Ramsdell AK, Manning BD, Sausville EA et al. (2006). The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. Cancer Cell 10: 133\u2013143.","journal-title":"Cancer Cell"},{"key":"BFonc2010411_CR32","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nrm1529","volume":"5","author":"A Sodhi","year":"2004","unstructured":"Sodhi A, Montaner S, Gutkind JS . (2004a). Viral hijacking of G-protein-coupled-receptor signalling networks. Nat Rev Mol Cell Biol 5: 998\u20131012.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2010411_CR33","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1073\/pnas.0400835101","volume":"101","author":"A Sodhi","year":"2004","unstructured":"Sodhi A, Montaner S, Patel V, Gomez-Roman JJ, Li Y, Sausville EA et al. (2004b). Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Proc Natl Acad Sci USA 101: 4821\u20134826.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2010411_CR34","first-page":"4873","volume":"60","author":"A Sodhi","year":"2000","unstructured":"Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA et al. (2000). The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60: 4873\u20134880.","journal-title":"Cancer Res"},{"key":"BFonc2010411_CR35","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa042831","volume":"352","author":"G Stallone","year":"2005","unstructured":"Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G et al. (2005). Sirolimus for Kaposi's sarcoma in renal-transplant recipients. N Engl J Med 352: 1317\u20131323.","journal-title":"N Engl J Med"},{"key":"BFonc2010411_CR36","first-page":"230","volume":"9","author":"T Szajerka","year":"2007","unstructured":"Szajerka T, Jablecki J . (2007). Kaposi's sarcoma revisited. AIDS Rev 9: 230\u2013236.","journal-title":"AIDS Rev"},{"key":"BFonc2010411_CR37","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/ncb1752","volume":"10","author":"A Taddei","year":"2008","unstructured":"Taddei A, Giampietro C, Conti A, Orsenigo F, Breviario F, Pirazzoli V et al. (2008). Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5. Nat Cell Biol 10: 923\u2013934.","journal-title":"Nat Cell Biol"},{"key":"BFonc2010411_CR38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature03987","volume":"437","author":"SM Weis","year":"2005","unstructured":"Weis SM, Cheresh DA . (2005). Pathophysiological consequences of VEGF-induced vascular permeability. Nature 437: 497\u2013504.","journal-title":"Nature"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2010411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010411","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2010411.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T17:28:49Z","timestamp":1647883729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2010411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,6]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,1,13]]}},"alternative-id":["BFonc2010411"],"URL":"https:\/\/doi.org\/10.1038\/onc.2010.411","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,6]]},"assertion":[{"value":"5 May 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}